� c���,) ��e (� � � - � �) GAIL (India) Limited (A Government of India Undertaking-A Maharatna Company) ND/GAIL/SE C TT/2021 f-i�- Listing--C�-�-pff�ce ! National Stock Exchange of : Limited Exchange Plaza, 5th Floor, Plot No. C/1, G Block, ! 2. India ! i Bandra-Kurla Complex, Bandra (East) Mumbai - 400051 � , 16�� � �-110066, � GAIL BHAWAN, 16 BHIKAIJI CAMA PLACE NEW DELHl-110066, INDIA / PHONE: +911126182955 �/FAX: +9111 26185941 t- 1 cVE-mail: info@gail.co in 18.08.2021 -------------------------------------------------- Listing Compliance BSE Limited Floor 1, Phiroze Jeejeebhoy Towers Dalal Street Mumbai -400001 S c r i p � - de: GAIL � _ Q _ ___ ___________________ j _______ S c r i p_ C o de: _ 53 2 _ 1 5_5 ________________________________ Sub.: Newspaper Publication of Dispatch of Notice of the 37 th AGM - Regarding Dear Sir, This is in compliance of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. With rerence to the subject cited above, please find the attachment. The above is r your inrmation and records. Thanking you, Yours ithlly, l (A.K. Jha) Company Secretary �/CIN L40200DL1984GOl018976 www.gailonline.com Encl: As above
3
Embed
-110066, c ,) e'5 NEW DELHl-110066, INDIA 16 BHIKAIJI CAMA ...
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
� c���,) ��e'5 (� � q,f � - � �)
GAIL (India) Limited (A Government of India Undertaking-A Maharatna Company)
ND/GAIL/SECTT /2021
f-i�- Listing--C�-�-pff �ce! National Stock Exchange of: Limited
� 'lfq,'f, 16�qj"jlCj"f� � �-110066, � GAIL BHAWAN, 16 BHIKAIJI CAMA PLACE NEW DELHl-110066, INDIA l:J>T-,/ PHONE: +911126182955 �/FAX: +9111 26185941 t-1'1cVE-mail: [email protected] in
Sub.: Newspaper Publication of Dispatch of Notice of the 37th AGM - Regarding
Dear Sir,
This is in compliance of Regulation 4 7 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
With reference to the subject cited above, please find the attachment.
The above is for your information and records.
Thanking you, Yours faithfully,
l (A.K. Jha) Company Secretary
x'ft�(fl/CIN
L40200DL1984GOl018976
www.gailonline.com
Encl: As above
MUMBAI | WEDNESDAY, 18 AUGUST 2021 COMPANIES 3. <
JSWInfraplanscapexof~10kcr
Flipkartwill open4centres inMaha,create4,000 jobsPEERZADAABRARBengaluru, 17 August
E-commercegiantFlipkartonTuesday said it will open fournew fulfilment and sortationcentres in Maharashtra, cre-ating4,000directandindirectjobs.
The facilities, located inBhiwandi andNagpur,will becollectively spread acrossnearly700,000squarefeet (sq.ft). Apart from growing cus-tomerdemand, theexpansioncomes on the back of a grow-ingsellercount fromthestate,which rose 30 per cent in thelast year.
“As a homegrown e-com-merce company, we are con-tinuouslymakingdeepinvest-ment in infrastructure andsupply-chain in Maharashtratosupporta robustecosystemfor local MSMEs, artisans,weavers and other under-served communities,” saidRajneeshKumar, chief corpo-rate affairs officer at Flipkart.
A fulfilment centre is awarehouse where orders arereceived,processedandfilled,
while a sortation centre is afacility where shipments arepickedaccordingtopincodes.Walmart-owned Flipkart hasover 70 of these across thecountry, spread over 10 mil-lion sq. ft.
Amazon India recentlyannounced plans to expandits fulfillmentnetwork,withanearly 40per cent increase inits storage capacity over thelast year. With this, Amazonwillhavemorethan43millioncubic feet of storage capacityacross 15 states.
JSW Infrastructure has planned a capex of~10,000 crore by 2025 and this will includeinvestments in logistics.
Logistics investment is a natural progres-sionintheportbusiness tostrengthenhinter-land connectivity.
“We have been accessing opportunities inrailconnectivitysincethe last6-8months.Wecouldinvest inrakes inthelastmilebut itcon-tinues to be a huge challenge. This would befor both our west as well as east coast opera-tions,” Arun Maheshwari, joint managingdirector (jointMD)andchief executiveofficer(CEO) at JSW Infrastructure told BusinessStandard.
Theunlisted company competeswithpri-vate port players such as Adani Ports, APMTerminalsandDPWorldintheIndianmarket.“Through this rail connectivity, we are plan-ning to have dedicated rakes, or leased rakesto see volumes increase for us as hinterlandconnectivitywill improve,” saidMaheshwari.
Part of the JSWGroup, JSWInfrastructurecurrentlyhas a capacity of 120million tonneswithits third-partycargogrowingoverthe lastfewyears.
ADITI DIVEKAR
The expansion comeson thebackof a growing sellercount in the state
SII buys 50% in vial makerSOHINIDASMumbai, 17 August
Serum Institute of India (SII)hasboughta50percentstakein drug vial maker Schott
Kaisha from its co-owners, KairusDadachanjiandShapoorMistry, foranundisclosed sum.
Schott Kaisha, a joint venturebetweenGermany’s specialtyglasscompany Schott AG and India’sKaishagroup, isa leadingmanufac-turer of pharmaceutical packagingproducts such as vials, syringes,ampoules andcartridges.
While the deal will help SII tohave more control over its supplychain (glass vials being a criticalcomponent of vaccine packaging),it will allow Kaisha to focus on itsother pharmaceutical ventures.
AdarPoonawalla,CEO,SII, said,“Even the best medication can’treach the patientwithout the rightpackaging. Securing this supplychain is of strategic importance.Schott is the perfect partner for usto do this because of its expertiseand global network.” “As a long-
time customer, we use SchottKaisha’s vials, ampoules, andsyringes to store our vaccines,includingCovishield.”
Sources in the know saidDadachanji andMistrywould nowfocus on bringing in new pharma-ceuticalproducts --bothdrugsanddrugdeliverysystems-- tothefrontend of the market. Kaisha groupcompanies such as SovereignPharmaarecontractmanufacturers
andmakedrugs like remdesivir forfirms likeCipla.
Dadachanji, managing directorof theKaisha group, said the groupwouldexpandits“horizon”tocaterto the front of the pharmaceuticalvaluechain.“Wewanttoworkmoreclosely with the medical commu-nity, and channelise our strengthsby bringing ease of drug adminis-tration to healthcare workers andhighly effectivemedication for our
end consumers,” he said. “My son,Rishad, and I will remain in closecontact with the industry throughour other businesses, namelySovereign Pharma, KaishaLifesciences, Kaisha Packaging,Kairish Innotech, and PackwellIndustries.”
Schott AG, owned by Carl ZeissFoundation, clocked a turnover of2.2 billion euros in the fiscal year2020. The 130-year-old companyhas presence in 34 countries and,thus, presents a good opportunityforSII totapthehigh-demandmar-ket of glass packaging of pharmaproducts.
Frank Heinricht, CEO, Schott,said, “We are looking forward tostrong impulses from this partner-ship. It is an excellent example ofshifting towards new cooperationmodels, with greater synergiesbetween pharma manufacturingandpackagingproduction.”
The joint venturewill definitelycontinuetosupply itscustomers inIndia and abroad, said EricL’Heureux, thenewMDandformerlongstanding head of operations.
“Due to lackofnewapprovals, Indiancompanies tried topush theexistingbasketofproducts, leading toadownward trend in
pricing,” saidanalysts.The firstquarterof 2021-22has seen
strongpriceerosion in theUSmarket.MostIndianpharmamajorshavepostedbothayear-on-yearandasequentialdip inUSrevenue.
SudarshanJain, secretarygeneral,
IndianPharmaceuticalAlliance -representingbigpharmaplayers in India -admitted toUSFDAauditshavinggonedownduring thepandemic.
The industryconcurs. “In thepastoneandahalf years, therehavebeensomedelays inUSFDAapprovals, especially thoserelated to facility inspections.Manyagencies fromothercountries (regulators),whichdidnot insist on facility inspections,didvirtual auditsorwentwith theearlieraudit results.Theapprovalshave, in fact,comedownduring thepandemic,” saidArunChandavarkar,managingdirector,BioconBiologics.
Healsoclarified that there is indeedsometalkof theUSFDAstartingvirtualaudits, but thosecouldpossibly start firstwithin theUS (domesticplants).
Indianaudits are likely topickup in thecomingmonths.VinitaGupta, chiefexecutiveofficerofLupin, said the Indiaofficeof theUSFDAis likely to resumesiteinspections soon.
INDIA’S SHARE REMAINS STABLE
H1CY19 H2CY19 H1CY20 H2CY20 H1CY21
670 501 430 398 328
267 171 176 168 137
40 34 41 42 42 Source:India Ratings
Indian firms’ share (% of total)
GlobalANDAapprovals
Indianfirms’ANDAapprovalsYoYdropin
1H21 (%)
-24GlobalANDAapprovals
-22IndianCos
ANDAapprovals
n Schott is a Germanspecialty glasscompany
n It had a 50:50 JVwith Kaisha Groupin India since 2008
n Schott Kaishainvested ~600 crorein last 3 years tobuild capacity
n Serum Institute hassecured control of
packaging materialsupplies
n Kaisha promotersnow plan to focuson their otherpharma businesses
×ð ¢ ×æñÁêÎ ãñ ¢, Üðç·UU U UÙ ÖØÖèÌ ãñ ¢Ð ·UU U U§ü×çãÜæ¥æð ¢ Ùð ¥æà梷UU U Uæ ÁÌæ§ü ãñ ç·UU U U¥ÈUU U U»æçÙSÌæÙ ·ðU U U U ÂéÙçÙü×æü‡æ ·ðU U U U ÎæñÚæÙ×çãÜæ¥æð ¢ ·UU U Uæ ð ¥æñÚ ¥çÏ·UU U UæÚ ÎðÙð ·UU U UæÂçà¿×è ÂýØæð» ÌæçÜÕæÙ ·ðU U U U àææâÙ ×ð¢·UUUUæØ× Ùãè¢ Úãð»æÐ